KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biogen (BIIB) Income from Non-Controlling Interests (2016 - 2023)

Biogen has reported Income from Non-Controlling Interests over the past 13 years, most recently at -$800000.0 for Q4 2023.

  • For Q4 2023, Income from Non-Controlling Interests rose 11.11% year-over-year to -$800000.0; the TTM value through Sep 2024 reached -$800000.0, down 366.67%, while the annual FY2023 figure was $400000.0, 100.47% up from the prior year.
  • Income from Non-Controlling Interests for Q4 2023 was -$800000.0 at Biogen, down from -$200000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $577.0 million in Q2 2021 and troughed at -$388.7 million in Q4 2021.
  • A 4-year average of $9.2 million and a median of -$300000.0 in 2020 define the central range for Income from Non-Controlling Interests.
  • On a YoY basis, Income from Non-Controlling Interests climbed as much as 795.96% in 2021 and fell as far as 129466.67% in 2021.
  • Year by year, Income from Non-Controlling Interests stood at -$300000.0 in 2020, then tumbled by 129466.67% to -$388.7 million in 2021, then skyrocketed by 99.77% to -$900000.0 in 2022, then rose by 11.11% to -$800000.0 in 2023.
  • Business Quant data shows Income from Non-Controlling Interests for BIIB at -$800000.0 in Q4 2023, -$200000.0 in Q3 2023, and $1.7 million in Q2 2023.